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Abstract
In the summer of 2010, two autochthonous dengue fever cases were detected in Croatia. Here we report the retrospective detection of an
additional case of dengue fever, representing the ﬁrst sustained autochthonous transmission in Europe since 1928. In addition, we present
the phylogenetic analyses based on two sequences from the Peljes ac peninsula, southern Croatia. The sequences were identiﬁed as dengue
virus genotype 1 and recovered from two out of the three Peljes ac patients in whom infection occurred.
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Abstract
The purpose of this study was to investigate the prevalence of herpes simplex virus (HSV) 1&2 in women screened for Chlamydia trachomatis
and/or Neisseria gonorrhoeae (CT/GC) infections. A total of 800 vaginal swabs were tested in a dual centre investigation, to evaluate the
prevalence of HSV-1&2 in this population. The average age of the population was 29.8  9.2 years, ranging between 14 and 66 years with a
median of 28 years. The highest prevalence of HSV-1 or HSV-2 was observed in the youngest age groups: teenagers and adults in their
twenties had 5.26% and 4.31% prevalence, respectively.
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Abstract
We conducted a retrospective study on the prevalence and correlates of transmitted drug resistance among newly-diagnosed antiretroviral
naive human immunodeﬁciency virus (HIV) patients in Northern Greece, during the period 2009–11. Transmitted drug resistance was
documented in 21.8% of patients enrolled, affecting approximately 40% of subtype A HIV-1-infected individuals. Overcoming challenges due
to the ongoing ﬁnancial crisis, effective preventive measures should be implemented to control further dissemination of resistant HIV
strains.
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